Tech-Med Convergence: Ping An's AI Margin Boost and Hansoh's Clinical WinsGlobal Report·Aug 18 at 04:43 AM01833+0.30%03692+1.93%
Hong Kong Equities Diverge as Infrastructure Expands and Healthcare Faces Governance TestsGlobal Report·Aug 11 at 05:13 AM01164-1.54%01199-1.14%
Inside the Hong Kong Biotech Rebound: BeiGene's Blockbuster Earnings and Venus Medtech's New LifelineGlobal Report·Aug 11 at 04:42 AM06160+0.99%02500+1.52%
Survival on the Fringes: Inside Hong Kong's Uncharted Equities in 2026Global Report·Aug 4 at 04:17 AM026800.00%080870.00%
The Under-the-Radar Rotation: CNOOC, Jiumaojiu, and Hidden Pockets of Hong Kong EquitiesGlobal Report·Jul 29 at 04:19 AM80883-0.83%09922+1.28%
Venus Medtech targets China, EU regulatory filings for Venus-PowerX TAVR systemPUBT·Jul 23 at 01:07 AM02500+1.52%
02:00 ETVenus Medtech anuncia la finalización del reclutamiento de pacientes para el ensayo clínico de Venus-PowerXprnewswire·Jul 23 at 01:00 AM02500+1.52%
Divergent Signals Across Hong Kong Equities: Infrastructure Resilience vs. Consumption HeadwindsGlobal Report·Jul 22 at 04:17 AM08540+0.23%02500+1.52%
Battery Tokens, Delisting Disasters, and Tencent’s Quiet AI TakeoverGlobal Report·Jul 15 at 04:13 AM02655+0.67%09963+5.42%
Venus Medtech Subscription Deal Lapses as Company Pursues New Financing PlanTip Ranks·Jul 5 at 05:37 PM02500+1.52%
